328 related articles for article (PubMed ID: 11806206)
1. [Treatment of HIV-infections: success or crisis?].
Pokrovskiĭ VV
Ter Arkh; 2001; 73(11):52-4. PubMed ID: 11806206
[No Abstract] [Full Text] [Related]
2. [Drugs for antiretroviral therapy. The costs of HAART].
Jablonowski H
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
[No Abstract] [Full Text] [Related]
3. Therapies. Confronting the limits of success.
Cohen J
Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
[No Abstract] [Full Text] [Related]
4. Trial suggests vaccines could aid HIV therapy.
Check E
Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722
[No Abstract] [Full Text] [Related]
5. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
Adlington R; Richens J; Shahmanesh M
J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
[No Abstract] [Full Text] [Related]
6. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV.
Corzillius M; Mühlberger N; Sroczynski G; Jaeger H; Wasem J; Siebert U
Antivir Ther; 2004 Feb; 9(1):27-36. PubMed ID: 15040534
[TBL] [Abstract][Full Text] [Related]
8. [AIDS treatment in Africa: the risk of antiretroviral resistance].
Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
[TBL] [Abstract][Full Text] [Related]
9. [New possibilities of the drug therapy of HIV infection].
Ristola M; Järvinen A
Duodecim; 1999; 115(20):2249-57. PubMed ID: 11973929
[No Abstract] [Full Text] [Related]
10. HIV-1 therapeutic vaccines.
Kinloch-de Loes S; Autran B
J Infect; 2002 Apr; 44(3):152-9. PubMed ID: 12099741
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy and vaccine against HIV infection].
Kimura S
Rinsho Ketsueki; 1995 May; 36(5):445-50. PubMed ID: 7783349
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
[TBL] [Abstract][Full Text] [Related]
13. Current developments in anti-HIV/AIDS gene therapy.
Tsygankov AY
Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
[TBL] [Abstract][Full Text] [Related]
14. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
[No Abstract] [Full Text] [Related]
15. Emerging manifestations of HIV/AIDS: is it the virus or the antiviral therapy?
Laurence J
AIDS Read; 2001 Feb; 11(2):64-5. PubMed ID: 11279873
[No Abstract] [Full Text] [Related]
16. Antiretroviral therapy and resistance to antiretroviral drugs.
Lange JM; van Leeuwen R
Ethiop Med J; 2002 Apr; 40 Suppl 1():51-75. PubMed ID: 12802831
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
18. HIV/AIDS in China. A new treatment campaign, but with limited weapons.
Cohen J
Science; 2004 Jun; 304(5676):1433. PubMed ID: 15178778
[No Abstract] [Full Text] [Related]
19. Highly active antiretroviral treatment in countries with very limited resources: do we have cheaper alternatives?
Colebunders R; Florence E; Lynen L; Bouckenooghe A
Int J STD AIDS; 2003 Jan; 14(1):1-5. PubMed ID: 12590784
[No Abstract] [Full Text] [Related]
20. Therapeutic vaccines against HIV need international partnerships.
Autran B; Debré P; Walker B; Katlama C
Nat Rev Immunol; 2003 Jun; 3(6):503-8. PubMed ID: 12776210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
